We further performed the bone marrow transplantation assay, finding that NEAT1_1, but not ΔNEAT1, could revert NEAT1−/−‐accelerated AML progression and mice death (Figure 7G). This evidence concerns the gene NEAT1 and acute myeloid leukemia.